An Application to Extend the Use of Rubraca for Treating Ovarian Cancer has Been Submitted to the European Medicines Agency
Free-Photos / Pixabay

An Application to Extend the Use of Rubraca for Treating Ovarian Cancer has Been Submitted to the European Medicines Agency

Clovis Oncology, Inc. has announced that they have submitted an application to the European Medicines Agency (EMA). The application is to extend the drug Rubraca’s®(rucaparib) marketing authorisation to include maintenance…

Continue Reading An Application to Extend the Use of Rubraca for Treating Ovarian Cancer has Been Submitted to the European Medicines Agency
Study Offers Free Screening for Cancer and BRCA Mutations for Ashkenazi Jewish Community
JoshMB / Pixabay

Study Offers Free Screening for Cancer and BRCA Mutations for Ashkenazi Jewish Community

According to a story from Jewish Community Voice, the BRCA Founder Outreach Study, which is a national, cancer-focused research study, is offering free screenings for people of Ashkenazi Jewish descent.…

Continue Reading Study Offers Free Screening for Cancer and BRCA Mutations for Ashkenazi Jewish Community
New Computational Framework Could Increase the Effectiveness of Cancer Treatment
Source: Pixabay

New Computational Framework Could Increase the Effectiveness of Cancer Treatment

According to a story from bioengineer.org, a group of scientists working at the Columbia University Irving Medical Center (CUIMC) have managed to develop a computational model that could potentially make highly…

Continue Reading New Computational Framework Could Increase the Effectiveness of Cancer Treatment
A Woman’s Severe Breast Cancer Was Eliminated Using New Immunotherapy Approach
silviarita / Pixabay

A Woman’s Severe Breast Cancer Was Eliminated Using New Immunotherapy Approach

According to a story from The Guardian, doctors are celebrating the effectiveness of an all new, experimental immunotherapy that was able to totally eliminate a case of metastatic breast cancer…

Continue Reading A Woman’s Severe Breast Cancer Was Eliminated Using New Immunotherapy Approach
Some People Are Resistant to PARP Inhibitors, and Researchers Have Just Discovered Why
source: pixabay.com

Some People Are Resistant to PARP Inhibitors, and Researchers Have Just Discovered Why

According to a story from Ovarian Cancer News, a recent study has allowed scientists to determine why some people appear to be resistant to poly ADP ribose polymerase (PARP) inhibitors.…

Continue Reading Some People Are Resistant to PARP Inhibitors, and Researchers Have Just Discovered Why